Clinical Trial Update: Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, pharmacokinetics, and clinical effects of cinacalcet in primary hyperparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Primary Hyperparathyroidism | Phase 2 | Status: COMPLETED